Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India

BACKGROUND: Sulfadoxine-pyrimethamine (SP) combination drug is currently being used in India for the treatment of Plasmodium falciparum as partner drug in artemisinin-based combination therapy (ACT). Resistance to sulfadoxine and pyrimethamine in P. falciparum is linked with mutations in dihydropter...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Divya, Lather, Manila, Mallick, Prashant K., Adak, Tridibes, Dang, Amita S., Valecha, Neena, Singh, Om P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574150/
https://www.ncbi.nlm.nih.gov/pubmed/26381498
http://dx.doi.org/10.1186/s13071-015-1080-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574150/
https://www.ncbi.nlm.nih.gov/pubmed/26381498
http://dx.doi.org/10.1186/s13071-015-1080-2

Ejemplares similares